We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Graft Polymer (uk) Plc | LSE:GPL | London | Ordinary Share | GB00BMD1Z199 | ORD GBP0.001 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.01 | -5.41% | 0.175 | 0.17 | 0.18 | 0.185 | 0.175 | 0.19 | 13,076,388 | 11:27:59 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Business Services, Nec | 587k | -3.12M | -0.0014 | -1.21 | 4.25M |
Date | Subject | Author | Discuss |
---|---|---|---|
15/11/2024 09:53 | Or the week after at the latest | gah123 | |
15/11/2024 09:53 | The big news on trials is expected next week | gah123 | |
15/11/2024 09:52 | That was on the 15th of Oct | gah123 | |
15/11/2024 09:27 | Edited, tie up with university of nottingham on 15 oct | pre | |
14/11/2024 20:39 | #GPL in fact the more i think about it the more i feel #GPL is about to moon.. this deal in the same sector is incredible .. #GPL market cap £4m.. this deal is worth £2billion | ssrover | |
14/11/2024 20:05 | This is the same sector as GPL .. GPL market cap £4m vs this deal worth £2billion | ssrover | |
14/11/2024 17:22 | you boys on the right thread ? | ssrover | |
14/11/2024 17:17 | Yusuf, That looks huuuge huuge massive bruv. Thanks blud. I owe you. You get me? | kemche | |
14/11/2024 17:09 | 2250000 million buy at 1.11p another buy of 1,000000 at 1.10 late trade showed up another 1,167690 buy top of riser board could be huge expecting 4.5p short term next stop 7.75p ticker gsc huge huge potential | yusuf77 | |
14/11/2024 16:50 | Imagine the price action when the herd arrive | gah123 | |
14/11/2024 16:21 | #GPL days highs paid and 100m volume and zero interest on twitter and bulletin boards.. suggest someone is loading heavy prior to clinical trials due anytime.. last time it went from 0.1p to over 1p in two days | ssrover | |
14/11/2024 15:09 | she’s on the live again with nearly 100m volume and hardly any noise on twitter on bulletin boards… break 20p and it goes wild prior to news | ssrover | |
14/11/2024 11:51 | Oh look it’s the dyslexic imbecile Blake who trolls every board 😂 | rw16 | |
14/11/2024 11:08 | Very strong management lead by Dennis Purcell, well funded with ground breaking IP - multiple deals and partnerships coming. That's what DP does. | gah123 | |
14/11/2024 11:07 | Just the start of the journey to 1p+ | gah123 | |
14/11/2024 11:06 | Time to take profits as heading back to 0.0015 | blakesmith | |
14/11/2024 09:11 | Myles McNulty @MylesMcNulty Graft Polymer #GPL has been climbing quietly under the radar the past three weeks, following the major pullback in the latter half of October. Now +50% since the lows. Definitely a buyer or two around. Do they know something? Probably. Eurofins study results due any day now, and I suspect new chairman Dennis Purcell has also been busy on new introductions and deals. As previously stated, I get the impression Dennis wants GPL as his preferred listed vehicle focusing on mental disorders. A mammoth new frontier in biotech. Graft Polymer’s existing technology is just the start for the Group. Quote | ssrover | |
14/11/2024 09:08 | A very quick turnaround anticipated for this pre-clinical study being carried out by Eurofins on behalf of #GPL - possibly as fast as two weeks. "The focus of this joint programme (with Awakn) is the development of next-generation medicines targeting trauma-related mental health conditions, such as Post-Traumatic Stress Disorder ("PTSD"), a condition affecting approximately 13 million adults in the U.S. and 20 million individuals across the US, UK, and key European markets. The aminoindane series being developed shows great promise in modulating key neurotransmitter systems involved in mental health conditions like PTSD. By targeting serotonin, dopamine, and noradrenaline reuptake, this pharmacological testing could unlock new therapeutic pathways for addressing trauma-related disorders." True frontier stuff. Just a tad punchy, on the R/R scales...! In the meantime, expecting new chairman Dennis Purcell to swiftly open doors to further collaborations and investment. For me, a momentum play in its nascent stages. Tiny mkt cap (£4m at 0.18p), cashed up, and new mgmt and shareholders with big ideas to grow this vehicle. | ssrover | |
14/11/2024 07:17 | should break 0.2s prior to news flow with a bit of wind is smackeraim still holding ? | ssrover | |
13/11/2024 20:51 | 54m volume out of nowhere.. no twitter noise and no posts here… suggests a leak to me.. half decent clinical results and this bags many times over just like it did in june what’s more mind blowing is the appointment of the new CEO.. why is he here at a £4m cap company ? GPL “Dennis is Founder and Senior Advisor at Aisling Capital. During his tenure, Dennis has been directly involved with over two hundred completed transactions and supervised over $15 billion of financing and advisory assignments in the pharmaceutical” | ssrover | |
13/11/2024 16:11 | must say the chart is most definitely curving up.. no noise on twitter as well | ssrover | |
10/11/2024 15:09 | Positive trial results should see 0.35p+, update imminent | gah123 | |
07/11/2024 22:44 | Just to let shareholders and prospective investors know that Graft Polymer will be presenting at Mello's 10-year anniversary show on Wednesday 20th November 2024 9am - 7pm. The Budget is out, Mello is in! To celebrate our 10 Year Anniversary, we have created a two-day investor conference that will include top quality keynote speakers including but not limited to Peter Pereira Gray, Paul Hill, Ben Rogoff, Rosemary Banyard and Gervais Williams. Also featuring panel sessions such as our popular Mello BASH (Buy, Avoid, Sell, Hold) with professional investors and analysts such as Leon Boros, Mark Simpson and Paul Scott. There will be over 40 exhibiting companies and over 60 presentations from companies such as The Property Franchise Group, Mortgage Advice Bureau, Time Finance, Aeorema and many more! Get 50% off your ticket with code MMTADVFN50. Tickets are still available: | mello2024 | |
23/10/2024 19:42 | The £10K marked as a sell was surly a worked buy at mates rates otherwise price would be down not up. | bri15 | |
23/10/2024 13:09 | Massive upside from this level,new CEO is the best. | bri15 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions